Biofortuna's Series B Round

Biofortuna raised a round of funding on March 14, 2012.

Biofortuna specializes in the development and manufacture of freeze-dried stabilized molecular diagnostics. The Company offers this technology on a custom service basis to global clients from the clin…

Articles about Biofortuna's Series B Round: